Lindsay Johnson, PA
Medical · Myrtle Beach, SCNPI 1972988590
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 446 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 446 payments — averaging $25.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$928
- Johnson & Johnson$915
- Sun Pharmaceutical Industries Inc.$885
- Incyte Corporation$764
- Regeneron Healthcare Solutions, Inc.$759
- plus $6K from 27 others
What the payments were for
- Food & beverage$10,51194%
- Education$6626%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 71 | $1,346 |
| Pfizer | 35 | $928 |
| Johnson & Johnson | 23 | $915 |
| Sun Pharmaceutical Industries Inc. | 39 | $885 |
| Incyte Corporation | 28 | $764 |
| Regeneron Healthcare Solutions, Inc. | 26 | $759 |
| Galderma Laboratories, L.p. | 48 | $610 |
| Amgen | 14 | $563 |
| Dermavant Sciences, Inc. | 18 | $513 |
| Sanofi | 16 | $452 |
| Almirall LLC | 13 | $358 |
| LEO Pharma Inc. | 15 | $317 |
| E.r. Squibb & Sons, L.L.C. | 11 | $305 |
| UCB, Inc. | 13 | $285 |
| Lilly USA, LLC | 16 | $281 |
| Novartis | 7 | $251 |
| Organon | 8 | $246 |
| Janssen Scientific Affairs, LLC | 2 | $221 |
| Boehringer Ingelheim | 6 | $197 |
| Arcutis Biotherapeutics, Inc. | 5 | $172 |
| Sanofi-aventis U.S. LLC | 2 | $170 |
| Organogenesis Inc. | 4 | $127 |
| Biofrontera Inc. | 5 | $103 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $95 |
| Kerecis Limited | 2 | $59 |
| Convatec Inc. | 2 | $54 |
| EPI Health, LLC | 3 | $48 |
| Genentech USA, Inc. | 2 | $44 |
| Verrica Pharmaceuticals Inc. | 2 | $35 |
| Merz North America, Inc. | 1 | $21 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Biowound Solutions, Inc. | 1 | $17 |
| Strata Skin Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,173 in reported general payments places this provider in the 95th percentile of 384 medical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 162 | $6,289 |
| Ketoconazole | 102 | $1,480 |
| Tretinoin | 45 | $1,328 |
| Mupirocin | 200 | $1,317 |
| Triamcinolone Acetonide | 86 | $929 |
| Ciclopirox | 30 | $838 |
| Clindamycin Phosphate | 26 | $791 |
| Doxycycline Hyclate | 56 | $611 |
| Mometasone Furoate | 45 | $491 |
| Metronidazole | 16 | $415 |
| Nystatin | 21 | $355 |
| Doxycycline Monohydrate | 19 | $301 |
| Levocetirizine Dihydrochloride | 11 | $133 |
| Cephalexin | 58 | $129 |
| Famotidine | 16 | $113 |
Paid to pharmacies, not to this prescriber.
Other medical in Myrtle Beach
- Bleselda ParagasMyrtle Beach$8K
- Tanya BralleyMyrtle Beach$7K
- Sanford HardinMyrtle Beach$5K
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Suzanne SmithWest Columbia$39K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
- Mary MacdonaldCharleston$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.